for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

BRIEF-Critical Outcome Technologies announces pharmacokinetic data from phase 1 dose escalation portion of COTI-2 trial

Nov 15 (Reuters) - Critical Outcome Technologies Inc

* Critical Outcome Technologies announces pharmacokinetic data from phase 1 dose escalation portion of COTI-2 trial in gynecological malignancies Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up